Azelis’ customers now have access to products including the well-established Polyglykol portfolio, as well as a brand-new range of Motusflex and VitiPure excipients.
These moves are designed to strengthen the company’s medical and scientific focus and support its continued record growth through closer alignment of all aspects of strategy, sales, and delivery to delight customers
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ, India
He has over two decades of rich experience in management consulting, advising and transforming leading generic pharmaceutical companies in India and global markets
They also noted ProBioGen's digitalization investments and strategy, as well as its support for its employees.
He takes over leadership of Cell & Gene from Jean-Christophe Hyvert, enabling Jean-Christophe to increase his focus on his role as President of the Biologics Division
85% of Agilent employees who responded to the survey indicated that the company is a great place to work
Investment further strengthens Merck's "Big 3," the key drivers for increasing Group sales to approximately € 25 billion by 2025
The OAI classification implies that the USFDA expects further corrective actions and may withhold approval of any pending product applications or supplements filed from this facility till the outstanding observations are resolved
Subscribe To Our Newsletter & Stay Updated
